Q
Q’Apel Medical
Health Tech & Medtech · Fremont, United States · Founded 2016
Designing novel access device technology for neurovascular interventions and unmet clinical needs MoreLess
Q'Apel Medical specializes in developing advanced neurovascular access and aspiration systems designed to improve stroke care. The company serves neurovascular specialists and healthcare providers focused on treating stroke patients. Operating in the medical device market, Q'Apel Medical's business model revolves around the design, manufacture, and sale of specialized catheters and aspiration systems. Revenue is generated through the direct sale of these medical devices to hospitals and healthcare facilities. Key products include the CHEETAH aspiration system, which offers rapid and visible clot engagement, and the ARMADILLO neurovascular access system, known for its balance between trackability and support. The company emphasizes innovation and collaboration with medical professionals to create solutions that address specific and urgent needs in stroke care. Keywords: neurovascular, stroke care, aspiration systems, catheters, CHEETAH, ARMADILLO, trackability, support, healthcare providers, medical devices.
Company overview
Q’Apel Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Fremont, United States
- Employees
- 115
- Open positions
- None listed
- Dealroom signal
- 75.4
Valuation & funding
Q’Apel Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2024 | $17M | $68M | Undisclosed | ↗ |
| LATE VCOther financing | Apr 2022 | $30M | $120M | Undisclosed | ↗ |
| SERIES COther financing | Feb 2021 | $22M | $88M | Research Corporation Technologies · Soleus Capital · RC Capital | — |
Growth signals
Q’Apel Medical website traffic
Latest recorded traffic for Q’Apel Medical is 2.1K monthly website visits, up 23.5% over the last three months. Q’Apel Medical's team declined 2.5% over the past year.
Hiring
Open positions at Q’Apel Medical
Current openings linked to this company in Dealroom.
Comparisons
Q’Apel Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Q’Apel Medical's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on Q’Apel Medical's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Q’Apel Medical has talent and traffic
team presence
In the news
Latest news about Q’Apel Medical
Recent press, funding announcements, and product moves mentioning Q’Apel Medical — open to read from the original sources.
Market sentiment
What the market is saying about Q’Apel Medical
An AI-synthesized read of the highest-engagement posts about Q’Apel Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Q’Apel Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.